I wonder how much they have changed the trans-resveratrol molecule in their proprietary formulation and if it still has the SIRT-1 activating effects. It would be nice to have a reliable source of resveratrol that has been proven bioavailable, active and stable. They are aiming for chemoprevention against breast- and colorectal cancer.
"RM1812 is a fully synthetic proprietary formulation of the naturally occurring small molecule Resveratrol. The compound has already obtained IND approval in the US and CTA approval in the UK and Canada for the conduct of early clinical trials. Three Phase I clinical trials in a total of ninety patients have successfully been completed, demonstrating the safety of RM1812 in human volunteers."
http://www.royalmoun...ent.asp?node=12